NCT00508326View on ClinicalTrials.gov

Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Advanced Cancer
Interventions
DRUG

Paclitaxel

Starting dose 150 mg/m\^2 HAI once every 4 weeks

Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00508326 - Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement | Biotech Hunter | Biotech Hunter